Synthetic Peptide
TOR Synthetic Peptide, PEP-0241, from Invitrogen.
FRAP1 (mTOR) is a serine/threonine kinase that plays a critical role in cellular growth and proliferation. Perturbations in the mTOR/PI3-kinase/AKT pathway are associated with numerous forms of cancer. FRAP1 is also the target of rapamycin and its analogues, which are currently used as immunosuppressants and cancer therapeutics. Mutations affecting the gene results in Smith-Kingsmore syndrome.
| Marque | Invitrogen |
|---|---|
| Réf. B-LABO | BL-RE-175973 |
| Réf. fabricant | 15246459 |
| Gene ID (Entrez) | 2475 |
| Espèces | Human |
| Méthode de purification | purified |
| Numéro d’adhésion | P42345 |
| Nom usuel | Human mTOR |
| Concentration | 200 μg/mL |
| Contenu et stockage | -20°C |
| Format | Liquid |
| Formule | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| À utiliser avec (application) | Blocking Assay, Control |
| Symbole de gène(s) | MTOR |
| Lyophilisé | No |
| Conservateur | 0.02% sodium azide |
| Type de produit | Peptide |
| Quantité | 50 μg |
| État réglementaire | RUO - research use only |
| Tampon de stockage | PBS |
